221 related articles for article (PubMed ID: 23137567)
1. Anticancer mechanisms and clinical application of alkylphospholipids.
van Blitterswijk WJ; Verheij M
Biochim Biophys Acta; 2013 Mar; 1831(3):663-74. PubMed ID: 23137567
[TBL] [Abstract][Full Text] [Related]
2. Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects.
van Blitterswijk WJ; Verheij M
Curr Pharm Des; 2008; 14(21):2061-74. PubMed ID: 18691116
[TBL] [Abstract][Full Text] [Related]
3. A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells.
van der Luit AH; Vink SR; Klarenbeek JB; Perrissoud D; Solary E; Verheij M; van Blitterswijk WJ
Mol Cancer Ther; 2007 Aug; 6(8):2337-45. PubMed ID: 17699729
[TBL] [Abstract][Full Text] [Related]
4. Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt/PKB survival pathway.
Ruiter GA; Zerp SF; Bartelink H; van Blitterswijk WJ; Verheij M
Anticancer Drugs; 2003 Feb; 14(2):167-73. PubMed ID: 12569304
[TBL] [Abstract][Full Text] [Related]
5. Lipid rafts and metabolic energy differentially determine uptake of anti-cancer alkylphospholipids in lymphoma versus carcinoma cells.
Vink SR; van der Luit AH; Klarenbeek JB; Verheij M; van Blitterswijk WJ
Biochem Pharmacol; 2007 Nov; 74(10):1456-65. PubMed ID: 17803969
[TBL] [Abstract][Full Text] [Related]
6. Rationale and clinical application of alkylphospholipid analogues in combination with radiotherapy.
Vink SR; van Blitterswijk WJ; Schellens JH; Verheij M
Cancer Treat Rev; 2007 Apr; 33(2):191-202. PubMed ID: 17287087
[TBL] [Abstract][Full Text] [Related]
7. Antitumor Lipids--Structure, Functions, and Medical Applications.
Kostadinova A; Topouzova-Hristova T; Momchilova A; Tzoneva R; Berger MR
Adv Protein Chem Struct Biol; 2015; 101():27-66. PubMed ID: 26572975
[TBL] [Abstract][Full Text] [Related]
8. Alkyl-lysophospholipids as anticancer agents and enhancers of radiation-induced apoptosis.
Ruiter GA; Verheij M; Zerp SF; van Blitterswijk WJ
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):415-9. PubMed ID: 11173135
[TBL] [Abstract][Full Text] [Related]
9. Edelfosine and miltefosine effects on lipid raft properties: membrane biophysics in cell death by antitumor lipids.
Castro BM; Fedorov A; Hornillos V; Delgado J; Acuña AU; Mollinedo F; Prieto M
J Phys Chem B; 2013 Jul; 117(26):7929-40. PubMed ID: 23738749
[TBL] [Abstract][Full Text] [Related]
10. Current view on the mechanism of action of perifosine in cancer.
Fensterle J; Aicher B; Seipelt I; Teifel M; Engel J
Anticancer Agents Med Chem; 2014 May; 14(4):629-35. PubMed ID: 24628236
[TBL] [Abstract][Full Text] [Related]
11. Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts.
Gajate C; Mollinedo F
Blood; 2007 Jan; 109(2):711-9. PubMed ID: 17003375
[TBL] [Abstract][Full Text] [Related]
12. Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis.
Ruiter GA; Zerp SF; Bartelink H; van Blitterswijk WJ; Verheij M
Cancer Res; 1999 May; 59(10):2457-63. PubMed ID: 10344758
[TBL] [Abstract][Full Text] [Related]
13. The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism.
Chiarini F; Del Sole M; Mongiorgi S; Gaboardi GC; Cappellini A; Mantovani I; Follo MY; McCubrey JA; Martelli AM
Leukemia; 2008 Jun; 22(6):1106-16. PubMed ID: 18385752
[TBL] [Abstract][Full Text] [Related]
14. Alkylphosphocholines and curcumin induce programmed cell death in cutaneous T-cell lymphoma cell lines.
Yosifov DY; Kaloyanov KA; Guenova ML; Prisadashka K; Balabanova MB; Berger MR; Konstantinov SM
Leuk Res; 2014 Jan; 38(1):49-56. PubMed ID: 24225136
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization and Akt phosphorylation inhibitory activity of cyclopentanecarboxylate-substituted alkylphosphocholines.
Alam MM; Joh EH; Park H; Kim B; Kim DH; Lee YS
Bioorg Med Chem; 2013 Apr; 21(7):2018-24. PubMed ID: 23415083
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Evaluation of Antitumor Alkylphospholipid Prodrugs.
Gaillard B; Remy JS; Pons F; Lebeau L
Pharm Res; 2020 May; 37(6):106. PubMed ID: 32462253
[TBL] [Abstract][Full Text] [Related]
17. Alterations in the homeostasis of phospholipids and cholesterol by antitumor alkylphospholipids.
Jiménez-López JM; Ríos-Marco P; Marco C; Segovia JL; Carrasco MP
Lipids Health Dis; 2010 Mar; 9():33. PubMed ID: 20338039
[TBL] [Abstract][Full Text] [Related]
18. The Akt-inhibitor Erufosine induces apoptotic cell death in prostate cancer cells and increases the short term effects of ionizing radiation.
Rudner J; Ruiner CE; Handrick R; Eibl HJ; Belka C; Jendrossek V
Radiat Oncol; 2010 Nov; 5():108. PubMed ID: 21080918
[TBL] [Abstract][Full Text] [Related]
19. Targeting the PI3K/Akt cell survival pathway to induce cell death of HIV-1 infected macrophages with alkylphospholipid compounds.
Lucas A; Kim Y; Rivera-Pabon O; Chae S; Kim DH; Kim B
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20927348
[TBL] [Abstract][Full Text] [Related]
20. The anti-tumor alkylphospholipid perifosine is internalized by an ATP-dependent translocase activity across the plasma membrane of human KB carcinoma cells.
Muñoz-Martínez F; Torres C; Castanys S; Gamarro F
Biochim Biophys Acta; 2008 Feb; 1778(2):530-40. PubMed ID: 18005660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
